Migden M, Guminski A, Gutzmer R, Loquai C, Squittieri N, Foley P. Hematology laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.3];7(2):s180. Available from: https://jofskin.org/index.php/skin/article/view/2010